Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-09

Clinical Trial Update: Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating induction chemotherapy followed by concurrent chemoradiotherapy with cetuximab in locally advanced head and neck squamous cell cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Head and Neck Squamous Cell Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-10-09